China SXT Pharmaceuticals-ASXTC
13F holders, Q1 2024 (March 31)4holders
$1.11avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding China SXT Pharmaceuticals-A (SXTC) in their 13F filings. The largest holders were Acadian Asset Management LLC ($3K), Qube Research & Technologies Ltd ($173) and UBS Group AG ($13).
- Company
- China SXT Pharmaceuticals-A
- CUSIP
- G2161P140
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $164K |
Ownership 4 holders
| Acadian Asset Management LLC | 0.00% | No change | 2,759 | $3K |
| Qube Research & Technologies Ltd | 0.00% | Add +3333.3% | 103 | $173 |
| UBS Group AG | 0.00% | Reduce -99.9% | 8 | $13 |
| Banque Cantonale Vaudoise | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is SXTC's weight in each manager's 13F, not the share of China SXT Pharmaceuticals-A the manager owns.